Chargement en cours...
Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
Although most differentiated thyroid cancers show excellent prognosis, treating radioiodine refractory differentiated thyroid cancer (RR-DTC) is challenging. Various therapies, including chemotherapy, radiotherapy, and targeted therapy, have been applied for RR-DTC but show limited effectiveness. Re...
Enregistré dans:
| Publié dans: | Front Endocrinol (Lausanne) |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5649198/ https://ncbi.nlm.nih.gov/pubmed/29085335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2017.00260 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|